CONCLUSION
This case summarizes that hyponatremia is an unusual adverse effect of long-standing use of SSRIs in middle aged adults under treatment for depressive disorders. Conclusively, this report shows the evidence for providers to be more cautious in monitoring patients with depressive disorders when given SSRIs as antidepressant therapy more often when the treatment is expected to stretch up to 10 years. Red flags such as signs and symptoms of hyponatremia must immediately be taken notice of including fits, convulsions or seizures.